A method for remote programming a therapy device for neurostimulation comprises: generating a stimulation program for the therapy device by means of a clinician programmer; transferring the stimulation program to a patient programmer; loading the stimulation program on the therapy device from the patient programmer; and increasing a stimulation amplitude of the stimulation program by means of the patient programmer. An initial stimulation amplitude setting of the stimulation program is limited to a minimal dose amplitude.

Systems and methods for producing physiological effects in response to simulated stimuli on living organisms are disclosed herein. In one example, a non-intrusive delivery of drug-simulating signals causes physiological effects on a living organism.

An implantable system for the diagnostic and/or therapeutic treatment of a human or animal patient contains a processor, a memory, a treatment unit and a remote data transmission unit. The system is characterized in that the memory includes a computer-readable program which prompts the processor to carry out the following steps when the program is being executed on the processor: a) ascertaining whether a treatment functionality of the treatment unit could jeopardize a patient in whom the system was implanted if a diagnostic and/or therapeutic treatment of the patient corresponding to the treatment functionality were to be carried out; b) deactivating the treatment functionality when a potential risk for the patient was ascertained; c) receiving reactivation data by way of the remote data transmission unit; and d) reactivating the deactivated treatment functionality based on the received reactivation data.

A system and method for facilitating remote care management involving a patient having an implantable medical device (IMD). Upon establishing a remote care session between a patient controller device and a clinician programmer, wherein the clinician and the patient are remotely located with respect to each other, input from the patient or the clinician may be received via a user interface control associated with a particular functionality or aspect of the remote care session, including audiovisual (AV) communications, remote therapy programming, and related context. Responsive to the user input, a dialog interface is effectuated at one of the patient controller device and/or the clinician programmer. A user characterization label is received via the dialog interface from the user, wherein the user characterization label is indicative of a subjective assessment of the particular functionality of the remote care session, which may be used in generating user-labeled data pertaining thereto.

A portable source medical device determines communication links of a network presently available to effect communications with a target component when the source medical device is at each of a multiplicity of geographical locations. A profile is generated comprising information about each available communication link and attributes associated with each available communication link for each geographical location. When the source medical device is at a particular geographical location, a profile associated with the particular geographical location is accessed and a network connection is established between the source medical device and the target component using a communication link associated with the particular profile. Medical information is transferred between the source medical device and the target component via the communication link associated with the particular profile.

An implantable medical device comprises a functional device for carrying out a therapeutic or diagnostic function, and a communication device for communicating with a remote monitoring system. The communication device, at a start of initial operation of the implantable medical device, is enabled to establish a communication with said remote monitoring system. In this way an implantable medical device is provided which allows for including the implantable medical device in a remote monitoring while reducing a risk for a patient involved with attending to the patient for activating a remote monitoring function within the implantable medical device.

An auditory neural interface device for sound perception by an individual that may be used as a hearing aid. The auditory neural interface device includes a receiver configured to receive sound signals, a processor operably connected to the receiver and configured to encode a received sound signal as a multi-channel neurostimulation signal, and a neurostimulation device operably connected to the processor and configured to apply the multi-channel neurostimulation signal to a neurostimulation electrode of the individual. The neurostimulation signal is configured to directly stimulate afferent sensory neurons of the central nervous system of the individual and thereby to elicit, for each channel of the neurostimulation signal, one or more non-auditory, preferably somatosensory, perceptions in a cortex area of the individual. Each channel of the neurostimulation signal is associated with a different non-auditory perception.

The disclosure relates to a device for transcutaneously transmitting energy into a human body. The device may include an extracorporeally arranged transmission device that includes an induction charging coil and a sensor. Upon receiving an electrical current, the induction charging coil may provide a magnetic field to inductively transmit energy to an induction coil arranged intracorporeally, transcutaneously powering a medical device, such as a mechanical circulatory support system within in the body. The sensor may provide a position signal representing a relative position between the induction charging coil and the induction coil. In turn the position signal may be used to position the extracorporeal induction coil so that energy it is concentrically aligned with the intracorporeal induction coil and energy can be efficiently transferred to the medical device.

An implantable medical device (IMD) performs, within a first predetermined time following an implantation, a first device test sequence over an evaluation period. The device test sequence includes at least two of: detecting an impedance for at least one electrical path having at least one electrode, and comparing the impedance to a first predetermined impedance threshold to determine a connection status of the IMD; comparing, over an electrogram (EGM) test period, at least one EGM event of the patient against a first predetermined EGM event threshold; determining a first pacing capture threshold of the IMD; and detecting at least one clinical or patient-specific physiologic metric, and comparing the physiologic metric to a first predetermined physiologic metric threshold. The IMD transmits within a second predetermined time a status signal to an external device indicating a status of at least one of the diagnostic tests in the first device test sequence.

A system and method for reducing or eliminating undesired effects of an artifact on a received signal is disclosed. The signal is generated from stimulating a sample. A receiver includes estimations of artifacts on the signal that are subtracted at different stages of the receiver. The estimations of the artifact may be performed via a successive approximation register scheme.